Drug Development

Sixth Annual Chair Summit Begins This Week

This week a Master Class for Neuroscience Development called the Chair Summit takes place in Tampa, FL (Sept 26-28, 2013). […]

By R Kennedy | Addiction . ADHD . Antipsychotic medication . Anxiety Disorders . Biomarker . Bipolar Disorder . Cardiovascular Risk Factors . Chronic Pain . CME . Dementia . Depression . Diabetes . Diagnosis . Digital medicine . Drug Development . Drugs . DSM-5 . Early intervention . Education . Food . Genetics . Guideline . Imaging . Maintenance of Certification . Measurement-based care . Medical Education . Mood . MRI . Multiple sclerosis . Negative symptoms . Neuroscience . Obesity . Opioids . PET . Practice guideline . Psychosis . PTSD . Research . Schizophrenia . Smoking cessation . Social media . Stroke . Substance abuse . Transcranial magnetic stimulation . Vascular dementia

DETAIL

Experts Convene to Focus on Medication-Development Slowdown

This month the American Psychiatric Association assembled experts from academia, the pharmaceutical industry, venture-capital firms, advocacy groups, and government agencies […]

By R Kennedy | Drug Development . Research

DETAIL